Skip to main content

Animations

MJFF Publications

6681 - 6690 of 8808 Results
Title
Year
  • Year
  • 2015
  • 2024
  • 2025
  • 2025
  • 2014
  • 2022
  • 2018
  • 2022
  • 2023
  • 2018
  • Summary Details
    OPEN
    Title: Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-015-0055-2
    Citation Count: 39
  • Summary Details
    OPEN
    Title: α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-024-00401-4
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70127
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Local Ionic Conditions Modulate the Aggregation Propensity and Influence the Structural Polymorphism of α-Synuclein
    Journal Name: Journal of the American Chemical Society
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/jacs.4c13473
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.01.042
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2022.809905
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007
    Citation Count: 126
  • Summary Details
    OPEN
    Title: Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies
    Journal Name: Neural Computing and Applications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00521-022-07256-8
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00555-4
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27487
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.